Rheumatology research output in the Arab World: despite the challenges

Submitted: 21 August 2022
Accepted: 3 October 2022
Published: 29 December 2022
Abstract Views: 823
PDF: 434
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Rheumatology is a field in which diagnostic, pathophysiological, and therapeutic advancements occur daily. These developments are the result of research in basic sciences, translational sciences, and clinical sciences. Physical and financial support, provided by individuals and institutions, is essential for all types of research. The political and economic instability in the Arab world has impacted the advancement of healthcare and the output of research. This review seeks to evaluate the quantity and quality of rheumatology-related research conducted in the Arab world. This review examined the number of rheumatological clinical publications produced by Arab countries between 2017 and 2021 and cited by PubMed/MEDLINE. Publications with authors from multiple nations were disqualified. Publications were then categorized by type, including randomized controlled trials (RCTs), cohort studies, cross-sectional studies, systematic reviews, narrative reviews, and case reports. Publications were also organized according to the regions of the Arab world: North and East Africa, the Middle East, and the Arabian Peninsula. The review also used data from the world bank to evaluate the gross domestic product (GDP) and total population of Arabian nations in order to calculate a ratio of publications to GDP and publications to population. Egypt had the highest number of publications among north and east African countries and Arab countries in general, with 261 publications, including the highest number of RCTs, which were 23. With 81 publications, Saudi Arabia had the highest number of publications on the Arabian peninsula. However, no individual country on the Arabian peninsula published an RCT. Lebanon had the most publications in the Middle East, but the majority were reviews and case reports. Tunisia had the highest ratio of publications to GDP. Notably, the number of publications increased during the coronavirus disease 2019 era in some countries. The Arab world is still able to produce clinical rheumatology publications despite its political instability and lack of resources. The influence of such publications on the daily practice of rheumatology is still debatable.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Berger DH. An introduction to obtaining extramural funding. J Surg Res. 2005; 128: 226-31. DOI: https://doi.org/10.1016/j.jss.2005.06.004
Batniji R, Khatib L, Cammett M, et al. Governance and health in the Arab world. Lancet. 2014; 383: 343-55. DOI: https://doi.org/10.1016/S0140-6736(13)62185-6
Bredan A. Conducting publishable research under conditions of severely limited resources. Libyan J Med. 2020; 15: 1688126. DOI: https://doi.org/10.1080/19932820.2019.1688126
El Achi N, Honein-Abouhaidar G, Rizk A, et al. Assessing the capacity for conflict and health research in Lebanon: a qualitative study. Conflict Health 2020; 14: 59. DOI: https://doi.org/10.1186/s13031-020-00304-x
Hakoum MB, Jouni N, Abou-Jaoude EA, et al. 2017. Characteristics of funding of clinical trials: cross-sectional survey and proposed guidance. BMJ Open 7: e015997 DOI: https://doi.org/10.1136/bmjopen-2017-015997

How to Cite

El Hasbani, G., Jawad, A., & Uthman, I. (2022). Rheumatology research output in the Arab World: despite the challenges. Reumatismo, 74(3). https://doi.org/10.4081/reumatismo.2022.1520

Similar Articles

<< < 14 15 16 17 18 19 20 21 22 23 > >> 

You may also start an advanced similarity search for this article.